Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Inflammopharmacology ; 32(2): 1401-1411, 2024 Apr.
Article in English | MEDLINE | ID: mdl-37610560

ABSTRACT

Folic acid (FA) plays an important role in the maintenance of normal neurological functions such as memory and learning function. Neuroinflammation contributes to the progression of cognitive disorders and Alzheimer's disease. Thus, this study aimed to investigate the effect of FA supplementation on cognitive impairment, oxidative stress, and neuro-inflammation in lipopolysaccharide (LPS)-injured rats. For this purpose, the rats were given FA (5-20 mg/kg/day, oral) for 3 weeks. In the third week, LPS (1 mg/kg/day; intraperitoneal injection) was given before the Morris water maze (MWM) and passive avoidance (PA) tests. Finally, the brains were removed for biochemical assessments. In the MWM test, LPS increased the escape latency and traveled distance to find the platform compared to the control group, whereas all doses of FA decreased them compared to the LPS group. The findings of the probe trial showed that FA increased the traveling time and distance in the target area. LPS impaired the performance of the rats in the PA test. FA increased delay and light time while decreasing the frequency of entry and time in the dark region of PA. LPS increased hippocampal levels of interleukin (IL)-6 and IL-1ß. The hippocampal level of malondialdehyde was also increased but thiol content and superoxide dismutase activity were decreased in the LPS group. However, treatment with FA restored the oxidative stress markers along with a reduction in the levels of pro-inflammatory cytokines. In conclusion, FA could ameliorate the memory and learning deficits induced by LPS via normalizing the inflammatory response and oxidative stress markers in the brain.


Subject(s)
Lipopolysaccharides , Memory Disorders , Rats , Animals , Rats, Wistar , Lipopolysaccharides/pharmacology , Memory Disorders/drug therapy , Memory Disorders/chemically induced , Neuroinflammatory Diseases , Folic Acid/adverse effects , Maze Learning , Oxidative Stress , Interleukin-6
2.
Metab Brain Dis ; 38(8): 2603-2613, 2023 12.
Article in English | MEDLINE | ID: mdl-37906392

ABSTRACT

Hypothyroidism causes learning and memory impairment. Considering the neuroprotective properties of thiamine (Vitamin B1), this study was conducted to investigate the effects of thiamine on acetylcholinesterase (AChE) activity, oxidative damage, and memory deficits in hypothyroid rats.In this study, 50 rats (21 days old) were randomly divided into 5 groups and treated with propylthiouracil (0.05% in drinking water) and thiamine (50, 100, and 200 mg/kg, oral) for 7 weeks. Following that, Morris water maze (MWM) and passive avoidance (PA) tests were performed. Finally, oxidative stress indicators and AChE activity were measured in brain tissue.Treatment of hypothyroid rats with thiamine, especially at 100 and 200 mg/kg, alleviated the ability to remember the location of the platform as reflected by less time spent and distance to reach the platform, during the MWM test (P < 0.05 to P < 0.001). In the PA test, the latency to enter the dark chamber and light stay time were increased in rats who received thiamine compared to the hypothyroid group (P < 0.05 to P < 0.001). In addition, thiamine increased the levels of total thiol groups and superoxide dismutase while decreasing the levels of malondialdehyde and AChE.Our results suggest that thiamine supplementation could effectively improve memory loss in a rat model of hypothyroidism. The positive effects of thiamin on the learning and memory of hypothyroid rats may be due to amelioration of redox hemostasis and cholinergic disturbance.


Subject(s)
Acetylcholinesterase , Hypothyroidism , Rats , Animals , Acetylcholinesterase/metabolism , Rats, Wistar , Hippocampus/metabolism , Oxidative Stress , Memory Disorders/drug therapy , Hypothyroidism/chemically induced , Hypothyroidism/complications , Hypothyroidism/drug therapy , Thiamine/pharmacology , Thiamine/therapeutic use , Maze Learning
3.
Work ; 67(3): 611-618, 2020.
Article in English | MEDLINE | ID: mdl-32986645

ABSTRACT

BACKGROUND: Work-related musculoskeletal disorders are the most common occupational health hazards. In the flour production industry, the fast pace of work, high frequency of repetitive movements, manual handling of loads, and awkward postures put a lot of pressure on the worker's body. OBJECTIVE: Given the high exposure of the workers of the flour production industry to ergonomic risk factors, this study aimed to reduce the rate of musculoskeletal disorders among a group of flour factory workers through ergonomic interventions. MATERIALS AND METHODS: This interventional study was performed using the census method on the eligible workers of a flour factory. An ergonomic intervention program was planned and implemented with the goal of reducing musculoskeletal disorders. The effectiveness of the program was evaluated by measuring the prevalence of musculoskeletal disorders before and six months after the interventions. RESULTS: Before the intervention, musculoskeletal disorders were most prevalent in the lower back, arms, shoulders, legs, thighs, knees, neck and wrists, respectively. Evaluation of the prevalence of musculoskeletal disorders after the intervention showed the positive effect of the ergonomic intervention program on musculoskeletal disorders in the neck, shoulders, lower back, thighs, knees, and legs (P < 0.05). CONCLUSION: Engineering and management interventions implemented in this study led to a significant reduction in the level of ergonomic risk factors and a reduced rate of musculoskeletal disorders among workers of different units in the flour factory.


Subject(s)
Musculoskeletal Diseases , Occupational Diseases , Occupational Health , Ergonomics , Flour , Humans , Musculoskeletal Diseases/epidemiology , Musculoskeletal Diseases/prevention & control , Occupational Diseases/epidemiology , Occupational Diseases/prevention & control , Prevalence
4.
Anat Sci Int ; 93(3): 351-363, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29177969

ABSTRACT

The aim of this study was to evaluate the effect of methamphetamine (MA) exposure during pregnancy and lactation on doublecortin (DCX) expression in the hippocampus of rat offspring and also on learning/memory. Thirty-five pregnant Wistar rats were randomly divided into seven groups of 5 rats each: three experimental groups, each receiving 5 mg/kg body weight (BW) intraperitoneal (i.p.) injections of MA during pregnancy or/and lactation; three sham groups, each receiving saline injections; one control group, receiving no injection. After the interventions, two male pups (1 and 22 days old) were randomly selected from each mother, sacrificed and their brains subjected to DCX immunohistochemistry. One additional male pup from each mother was randomly selected and maintained for 60 days for testing in the Morris water maze and passive avoidance tests. MA administration during pregnancy was found to have significantly decreased the number of DCX-positive cells in the CA1, CA3 and DG regions of the hippocampus in the 1-day pups (P ≤ 0.05) and to have significantly decreased the number of DCX-positive cells in only two regions of the hippocampus, the CA1 and DG regions, in 22-day old pups. In comparison, exposure to MA during lactation was only associated with a significant decrease in the number of DCX-positive cells in the DG. Exposure to MA during pregnancy had significant impact on the intensity of DCX expression in the hippocampus of 1- and 22-day pups (P ≤ 0.05). There was no significant difference in memory/learning among the study groups. Our results indicate the administration of MA during pregnancy had a greater effect that during the lactation period on DCX expression in the hippocampus of rat offspring.


Subject(s)
Hippocampus/metabolism , Lactation/metabolism , Learning/drug effects , Maternal Exposure/adverse effects , Maternal-Fetal Exchange , Memory/drug effects , Methamphetamine/adverse effects , Microtubule-Associated Proteins/metabolism , Neuropeptides/metabolism , Pregnancy, Animal/metabolism , Prenatal Exposure Delayed Effects/metabolism , Prenatal Exposure Delayed Effects/psychology , Rats, Wistar/metabolism , Rats, Wistar/psychology , Animals , Doublecortin Domain Proteins , Doublecortin Protein , Female , Male , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...